Dr.
Kathleen Elizabeth Rodgers
Titus Family Department of Clinical Pharmacy and
Pharmaceutical Economics and Policy
School of Pharmacy
University of Southern California, USA
Associate Professor
Email: krodgers@pharmacy.usc.edu
Qualifications
1984 Ph.D., University of California,
Organophosphorus Immunotoxicity
1980 B.Sc., University of California, Cell
Biology
Publications
(selected)
-
diZerega, G.S. and Rodgers, KE. The
Peritoneum. Springer Verlag, 1992.
-
diZerega, G.S. DeCherney A.H., Diamond M.P., Dunn
R. C., Goldberg E. P., Haney A.F., Rock J.A., Tulandi T., and Rodgers K.E.
Pelvic Surgery. Springer Verlag, 1997.
-
diZerega, G.S. DeCherney A.H., Diamond M.P., Ellis
H., Gomel V., Haney A.F., Holmdahl L., Rock J.A., Rodgers K.E., Thompson J.
Peritoneal Surgery. Springer Verlag,
2000.
-
Roks AJ, Rodgers K, Walther T. Effects of the renin
angiotensin system on vasculogenesis-related progenitor cells. Curr Opin
Pharmacol. 2011 Apr; 11(2): 162-74.
-
Rodgers KE, Burleson FG, Burleson GR, Lewis KM,
Wolfsegger MJ, and Redl H. A Two-Component Polyethylene Glycol Sealant as an
Adhesion Prevention Device Does Not Influence Intraperitoneal Infection in a
Refined Animal Model. American Journal of Obstetrics and Gynecology, 2010
Nov; 203(5): 494. e1-6.
-
Eidenschink, L, diZerega, GS, Rodgers, KE,
Bartlett, Loken, MR. Basal levels of CD34 positive cells in peripheral blood
differ between individuals and are stable for 18 months, Cytometry Part B
(Clinical Cytometry), 2011 82B: 18-25.
-
Rodgers KE, Verco S, Bolton, LL, diZerega GS.
Accelerated Healing of Diabetic Wounds by NorLeu3-Angiotensin II(1-7), Expert
Opinion on Investigational Drugs, 2011
Nov; 20(11):1575-81. Epub 2011 Oct 6.
-
Mordwinkin NM, Russell J, Burke AS, diZerega G,
Louie SG, Rodgers KE. Toxicological and Toxicokinetic Analysis of Angiotensin
(1-7) in Two Species, Journal of Pharmaceutical Sciences, 2012
Jan; 101(1): 373-380.
-
Mordwinkin NM, Meeks CJ, Jadhav SS, Espinoza T,
Roda N, DiZerega GS, Louie SG, Rodgers KE. Angiotensin-(1-7) administration
reduces oxidative stress in diabetic bone marrow. Endocrinology,
153(5): 2189-97.
-
Balingit, P; Armstrong, DG; Reyzelman, AM; Bolton,
L; Verco, SJ; Rodgers, KE; diZerega, GS. Randomized, Parallel-Group,
Double-Blind, Placebo-Controlled Phase II Clinical Trial to Evaluate the Safety
and Effectiveness of NorLeu3-A (1-7) in Treating Subjects with Diabetic Ulcers,
Wound Repair and Regeneration, 20: 482-490.
-
Rodgers KE, Espinoza TE, Roda N, Meeks CJ, Hill C,
Louie SG, and diZerega GS. Accelerated Hematopoietic Recovery with
Angiotensin-(1-7) after Total Body Radiation, International Journal of
Radiation Biology, 2012 Jun; 88(6): 466-76.
-
Rodgers KE. Hemocompatibility. In Encyclopedia of Toxicology, Volume 2, (Ed
Phillip Wexler) Elseiver, Oxford UK, 2011.
-
Rodgers KE. Idiopathic Environmental
Intolerance. In Encyclopedia of
Toxicology, Volume 3, (Ed Phillip Wexler) Elseiver, Oxford UK, 2011.